BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kumar R, Kumar A, Kumar S. Acute liver failure from anti-tuberculosis drug-induced liver injury: An update. World J Hepatol 2025; 17(5): 106618 [PMID: 40501479 DOI: 10.4254/wjh.v17.i5.106618]
URL: https://www.wjgnet.com/1948-5182/full/v17/i5/106618.htm
Number Citing Articles
1
Juan C. Polo, Jesus M. Angulo-Mercado, Sandra M. Coronado-Ríos, Fernando de la Vega, Edwin D. Correa, Nelson E. Arenas. Dynamic Biochemical Phenotypes in Hospitalized Patients with Pulmonary Tuberculosis. Sci 2026; 8(2) doi: 10.3390/sci8020035
2
Tomislava Skuhala, Anja Dragobratović, Luka Marinković, Kristina Ramljak, Marin Rimac, Arijana Pavelić, Snjezana-Zidovec Lepej. Antitubercular Drug-Induced Liver Injury in the Treatment of Tuberculous Lymphadenitis: A Comprehensive Review. Livers 2026; 6(2) doi: 10.3390/livers6020019
3
Yang Hao, Xiaoqing Zhang, Daiyun Huang, Shengyin Qin, Yunxiao Lin, Jianwen Ruan, Lu Shen, Na Zhang, Zhenting Wang, Cong Huai, Jianquan Zhang. Whole-exome sequencing reveals cumulative rare variant burden associated with susceptibility to anti-tuberculosis drug-induced liver injury in a Han Chinese cohort. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1952049
4
Yining Liu, Zhenhui Liu, Chenjunlei Luo, Wenyan Chen, Zihao Xia, He Zhou, Junfei Huang, Mingdan You, Guanghong Yang. Baicalein mitigates anti-tuberculosis-induced liver injury via inhibition of lipid peroxidation mediated by ferritinophagy and ferroptosis: Involvement of Yap 1/NCOA4 signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2026; 1872(8) doi: 10.1016/j.bbadis.2026.168328
5
Yurou Li, Zhenzhen Yan, Wanrong Zhang, Xin Zheng, Zhengping Wu, Yinjie Jiang, Jie Zhou. Sodium aescinate induces hepatocyte ferroptosis through the Nrf2/PRDX6/GPX4 axis. Archives of Biochemistry and Biophysics 2026; 781 doi: 10.1016/j.abb.2026.110826
6
Jovan Javorac, Ana Milenkovic, Emilija Vujicic, Dragica Kovacevic, Tijana Rudic-Vranic, Darko Mikic, Dejan Zivanovic. Antituberculosis drug-induced liver injury: Current concepts in pathogenesis, diagnosis, and management. Vojnosanitetski pregled 2026; 83(7) doi: 10.2298/VSP260329039J
7
Irfan Malik, Nosheen Farooq, Maheen Sheraz, Bilal Aslam, Umama Alam, Umer Sajid, Fatima Sajjad, Kamil Ahmad Kamil. Coexisting Hepatic and Renal Dysfunction During Pulmonary Tuberculosis Treatment: A Case Report. Clinical Case Reports 2026; 14(5) doi: 10.1002/ccr3.72661
8
Abhishek Kumar, Ramesh Kumar, Vijay Kumar, Sudhir Kumar, Sudheer Marrapu, Utpal Anand, Rajeev N. Priyadarshi. Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study. Journal of Clinical and Experimental Hepatology 2025; 15(6) doi: 10.1016/j.jceh.2025.103124
9
Irene Díaz-Alberola, Daniel E. Di Zeo-Sánchez, Vanesa Garrido-Rodríguez, Carlos López-Gómez, Cristina Rodríguez-Díaz, Raul J. Andrade, M. Isabel Lucena, Marina Villanueva-Paz, Eduardo García-Fuentes. The gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system. Acta Pharmaceutica Sinica B 2026; 16(7) doi: 10.1016/j.apsb.2026.04.014
10
Debasree Bishnu, Suman Santra, Partha Sarathi Mukherjee, Gopal Krishna Dhali, Abhijit Chowdhury, Amal Santra, Dirk Uhlmann. Unveiling the Cellular Mystery of Isoniazid–Rifampicin (IR) in CYP2E1 Overexpressing HepG2 Cells. International Journal of Hepatology 2026; 2026(1) doi: 10.1155/ijh/9275461
11
Marcin Ziomek, Łukasz Świątek, Liliya V. Mihaylova, Martina S. Savova, Milen I. Georgiev, Elwira Sieniawska. Recent advances in metabolomics of mycobacteria and tuberculosis: From species differentiation to pharmacometabolomics and personalized therapy. Journal of Pharmaceutical Analysis 2026;  doi: 10.1016/j.jpha.2026.101817
12
Mingyang Hong, Xu Huang, Huiming Zhu, Jiahui Ma, Yajun Sun, Feng Li. Modulation of anti-tuberculosis drug-induced liver injury by gut microbiota metabolites: Insights from network pharmacology. International Microbiology 2026;  doi: 10.1007/s10123-026-00911-3
13
Tariq Abdullah, Abdul Khalid, Mehwish Mumtaz, Mazhar Hamdani, Muhammad Ali Shahid. The Frequency of Raised Liver Enzyme in Patients on Anti-Tuberculosis Drugs. Pakistan Journal of Health Sciences 2026;  doi: 10.54393/pjhs.v7i4.4112